In 2020, 264 million U.S. dollars were paid in upfront cash and equity for mergers and acquisitions worldwide involving companies developing biopharma therapeutics and tech platforms. This statistic illustrates the average value of private biopharma M&A upfront cash and equity worldwide from 2008 to 2020.
Average value of private biopharma M&A upfront cash and equity worldwide from 2008 to 2020*
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
DealForma. (February 17, 2021). Average value of private biopharma M&A upfront cash and equity worldwide from 2008 to 2020* (in million U.S. dollars) [Graph]. In Statista. Retrieved November 13, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240358/average-value-private-biopharma-ma-upfront-cash-and-equity/
DealForma. "Average value of private biopharma M&A upfront cash and equity worldwide from 2008 to 2020* (in million U.S. dollars)." Chart. February 17, 2021. Statista. Accessed November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240358/average-value-private-biopharma-ma-upfront-cash-and-equity/
DealForma. (2021). Average value of private biopharma M&A upfront cash and equity worldwide from 2008 to 2020* (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240358/average-value-private-biopharma-ma-upfront-cash-and-equity/
DealForma. "Average Value of Private Biopharma M&a Upfront Cash and Equity Worldwide from 2008 to 2020* (in Million U.S. Dollars)." Statista, Statista Inc., 17 Feb 2021, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240358/average-value-private-biopharma-ma-upfront-cash-and-equity/
DealForma, Average value of private biopharma M&A upfront cash and equity worldwide from 2008 to 2020* (in million U.S. dollars) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240358/average-value-private-biopharma-ma-upfront-cash-and-equity/ (last visited November 13, 2024)
Average value of private biopharma M&A upfront cash and equity worldwide from 2008 to 2020* (in million U.S. dollars) [Graph], DealForma, February 17, 2021. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240358/average-value-private-biopharma-ma-upfront-cash-and-equity/
